Coronado Biosciences, Inc. (NASDAQ:CNDO)

CAPS Rating: 2 out of 5

Results 1 - 1 of 1

Recs

1
Member Avatar jcarnoldsf (41.19) Submitted: 1/25/2012 6:12:22 PM : Outperform Start Price: $6.18 CNDO Score: +25.72

This young biotech has a top-notch management team and an exciting roster of drugs entering final stage testing. The drugs are targeting autoimmune diseases and cancer. The most novel is an approach using parasites to activate the immune system. Has potential to be a big winner - buy now while it's still cheap!

Report this Post Reply
Results 1 - 1 of 1

Featured Broker Partners


Advertisement